Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1 CNS 1

Conditions

Squamous Cell Carcinoma of Head and Neck 4 Neoplasms 3 Neoplasms by Site 2 Neoplasms by Histologic Type 2 Neoplasm Metastasis 2 Leukemia, Myeloid, Acute 2 Carcinoma, Squamous Cell 2 Carcinoma, Non-Small-Cell Lung 2 Carcinoma 2 Vascular Diseases 1 Thoracic Neoplasms 1 Respiratory Tract Neoplasms 1 Respiratory Tract Diseases 1 Recurrence 1 Pathologic Processes 1 Paraproteinemias 1 Pancreatic Neoplasms 1 Oropharyngeal Neoplasms 1 Neoplastic Processes 1 Neoplasms, Plasma Cell 1 Neoplasms, Glandular and Epithelial 1 Multiple Myeloma 1 Mouth Neoplasms 1 Lymphoproliferative Disorders 1 Lymphoma 1 Lymphoid Interstitial Pneumonia 1 Lymphatic Diseases 1 Lung Neoplasms 1 Lung Diseases 1 Liver Neoplasms 1

Interventions

Temozolomide 130 Radiotherapy 86 Bevacizumab 43 Radiation 31 Carmustine 29 Irinotecan 22 Erlotinib Hydrochloride 22 Magnetic Resonance Spectroscopy 21 Chemotherapy, Adjuvant 20 Surgical Procedures, Operative 15 O(6)-benzylguanine 15 Carboplatin 14 Radiotherapy, Intensity-Modulated 13 Radiotherapy, Conformal 13 sargramostim 12 Sirolimus 9 Imatinib Mesylate 9 Filgrastim 9 Drug Therapy 9 temsirolimus 8 Thalidomide 8 Sorafenib 8 Radiosurgery 8 pembrolizumab 7 motexafin gadolinium 7 aldesleukin 7 Vorinostat 7 Procarbazine 7 Gefitinib 7 Cyclophosphamide 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Gliosarcoma × ficlatuzumab × Clear all

NCT01189513 2012-02-20

SCH-900105 in Recurrent Glioblastoma

M.D. Anderson Cancer Center

Phase 1 Withdrawn

Glioblastoma, Gliosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡